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Abstract
Background: The aim of this study was to investigate viral shedding in otherwise healthy children with pandemic
A/H1N1/2009 influenza in order to define how long children with pandemic A/H1N1/2009 influenza shed the virus,
and also plan adequate measures to control the spread of the disease within households.
Findings: In 74 otherwise healthy children with pandemic A/H1N1/2009 influenza, nasopharyngeal swabs were
taken for virus detection upon hospital admission and every two days until negative. The nasopharyngeal swabs of
all of the children were positive for pandemic A/H1N1/2009 influenza virus in the first three days after the onset of
infection, and only 21.6% and 13.5% remained positive after respectively 11 and 15 days. No child was positive
after more than 15 days. Viral load also decreased over time, and was not associated with patient age or the risk of
pneumonia. Those who shed the virus for ≥ 9 days were not at any increased risk of suffering from more severe
disease in comparison with those who shed the virus for a shorter time, but their households experienced a
significantly higher number of influenza-like illness during the two weeks after the onset of the initial disease
(72.3% vs 41.4%; p < 0.05).
Conclusions: Regardless of their age, healthy children can shed pandemic A/H1N1/2009 influenza virus for up to
two weeks after illness onset, and the households of the children who shed the virus for ≥ 9 days suffered a
higher number of influenza-like illness in the two weeks following the onset of the first disease. This could suggest
that when a completely unknown influenza virus is circulating, isolation period of infected children has to be
longer than the 7 days recommended for the infections due to seasonal influenza viruses.
Findings
T h el e n g t ho ft i m ea ni n f l u e n za infection is contagious
is mainly related to the amount and duration of virus
shedding [1]. In the case of seasonal influenza, it has
been shown that shedding generally coincides with
symptom onset, peaks on the second day, and generally
lasts for about one week [2]. However, this duration is
greatly affected by age and may be longer in young chil-
dren, thus justifying the assumption that pediatric
patients are the main cause of the spread of influenza in
the community [3].
The pediatric data concerning the shedding of the
novel pandemic A/H1N1/2009 influenza virus are not
conclusive because some studies seem to indicate that
the virus is shed for a longer time in younger patients
than in adults [4], and others that the shedding is not
age-related [1,5]. The aim of this study was to investi-
gate viral shedding in otherwise healthy children with
pandemic A/H1N1/2009 influenza in order to define
how long children with pandemic A/H1N1/2009 influ-
enza shed the virus, and plan adequate measures to con-
trol the spread of the disease within households.
This study was approved by the Institutional Review
Board of the Fondazione IRCCS Ca’ Granda Ospedale
Maggiore Policlinico, Milan, Italy. The patients were
enrolled by the Department of Maternal and Pediatric
Sciences of the University of Milan during the peak per-
iod of pandemic A/H1N1/2009 influenza (from 1
November to 15 November 2009) after both parents or
the legal guardian of the children had given their written
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their assent.
The study involved otherwise healthy subjects aged
less than 15 years without any underlying chronic severe
disease who attended our Emergency Room or were
hospitalised because of an influenza-like illness as
defined by the Italian Ministry of Health http://www.
ministerosalute.it. Only the children whose symptoms
had appeared in the 48 hours preceding hospital atten-
dance were enrolled. Patients with serious complications
related to pandemic A/H1N1/2009 influenza who
required antiviral treatment were also excluded.
After collecting data concerning the patients’ previous
clinical history and the exact time of the onset of signs
and symptoms of A/H1N1/2009 influenza (including
fever), all of the children underwent a complete physical
examination and were divided into disease groups on the
basis of signs and/or symptoms using well-established
criteria (i.e., common cold, acute pharyngotonsillitis,
acute otitis media, croup, acute bronchitis, acute wheez-
ing, radiographically-confirmed pneumonia) [6]. The
children with radiographically-confirmed pneumonia (all
of whom required hospitalisation) were considered sepa-
rately from those who were not hospitalized and had evi-
dence of upper respiratory tract symptoms or lower
respiratory tract symptoms but without evidence of
pneumonia.
Upon enrolment, a nasopharyngeal sample for the
diagnosis of pandemic A/H1N1/2009 influenza infection
was collected. A further swab was taken from all of the
positive cases on the third day after the onset of disease
and afterwards every two days until two were negative.
During the collection of the respiratory secretions, the
medical history of each child was re-evaluated (in the
outpatient clinic if they had been discharged or in the
ward if they were hospitalised), and information was
obtained about the occurrence of influenza-like illness
(ILI) and the related morbidity in their households. At
this regard, only subjects permanently living at home
together with the infected child were considered and in
case of hospitalization of the enrolled child only those
who had taken care daily of the patient during the
whole period of the stay in the hospital.
All of the nasopharyngeal samples were collected
using a pernasal flocked swab, and stored in a tube of
U T M - R T( K i tC a t .N o .3 6 0 c ,C o p a nI t a l i a ,B r e s c i a ,
Italy). Viral RNA was extracted by means of a Nuclisens
EasyMAG automated extraction system (bioMeriéux,
Bagno a Ripoli, Florence, Italy), as previously described
[7]. Real-time polymerase chain reaction (real-time PCR)
was used to identify influenza A and B viruses using
previously validated methods [7]. In the case of influ-
enza A-positive samples, the WHO/CDC protocol was
used to characterise those positive for pandemic A/
H1N1/2009 influenza [8].
A plasmid containing the corresponding target viral
sequence was used to quantify viral load in the A/
H1N1/2009-positive samples. Ten-fold plasmid serial
dilutions ranging from 5 to 5 × 10
7 input copies were
prepared to generate calibration curves, and run in par-
allel with the tested samples. The cycle threshold values
of each dilution were measured in duplicate and plotted
against the logarithm of their initial quantities, and the
copy numbers in each clinical sample were derived from
the regression line. The quantitative results were
expressed as RNA copy number/mL of nasopharyngeal
swab following data multiplication by 50. In order to
evaluate reproducibility, intra- and inter-assay standard
deviations (SDs) and coefficients of variation were calcu-
lated for each standard concentration within and
between the individual PCR runs.
Mean viral shedding was calculated and plotted by year
of age, a diagnosis of pneumonia, and the occurrence of
acute respiratory illness in at least one family member.
Wilcoxon’s rank-sum test was used to assess the
between-group differences. In the case of categorical
data, the groups were compared using contingency table
analysis with the c
2 or Fisher’s exact test, when appropri-
ate. All of the analyses were two-tailed, and p values of
0.05 or less were considered statistically significant.
Of the 74 children enrolled (36 males; mean age ± SD,
5.2 ± 4.9 years), 44 (59.4%) were hospitalised because of
pneumonia and classified as suffering from severe disease.
Table 1 shows the mean viral loads (log10 cp/mL) and the
number of children shedding virus at different times after
the onset of pandemic A/H1N1/2009 influenza. The naso-
pharyngeal swabs of all of the children were positive for
pandemic A/H1N1/2009 influenza virus in the first three
days after the onset of infection, but the number of posi-
tive samples decreased over time and only 21.6% and
13.5% remained positive after respectively 11 and 15 days
regardless of patient age. No child was positive after more
than 15 days. Fever disappeared 3-4 days after enrolment
in both the hospitalised and non-hospitalised patients
regardless of viral shedding.
Viral load also decreased over time, and was not asso-
ciated with patient age. Moreover, no relationship was
found between duration of viral shedding and risk of
development of pneumonia because the percentage of
children who shed the virus for ≥ 9 days and were
admitted to the hospital for pneumonia was similar to
that of those who shed the virus for a shorter time and
were hospitalized for pneumonia (68.5% vs 51.2%; p >
0.05). However, households of children with prolonged
shedding (≥ 9 days) experienced a significantly higher
number of ILI during the two weeks after the onset of
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virus for less than 9 days (72.3% vs 41.4%; p < 0.05).
Our findings show the natural viral shedding profile of
children infected with pandemic A/H1N1/2009 influ-
enza virus because none of the enrolled children
received any antiviral drug capable of interfering with
virus replication during the observation period. More-
over, as only otherwise healthy children were enrolled,
they add useful information concerning the real period
during which most children spread the infection in the
community.
Regardless of their age, healthy children can shed pan-
demic A/H1N1/2009 influenza virus for up to two weeks
after illness onset. Furthermore, the shedding can persist
for some days after the cessation of fever. As has been
observed in other studies [1,2,9], viral load significantly
decreased over time, varying from about 8 log10 cp/mL in
the first days to more than 3 log10 cp/mL in the second
week. All of our data seem to suggest that the World
Health Organisation (WHO) guidelines for the clinical
management of human infection with pandemic A/
H1N1/2009 influenza virus should be considered cau-
tiously [10]. The WHO guidelines indicate that patients
with pandemic influenza symptoms should be precautio-
narily isolated for seven days after the onset of illness or
24 hours after the resolution of fever which, on the basis
of our findings, seems to be too short a period to avoid
the risk of spreading the infection. Furthermore, the sig-
nificantly greater number of ILI diagnosed in the house-
holds of children who shed the virus for ≥ 9 days
suggests that prolonged shedding increases the risk. This
could mean that, in order to reduce the risk of transmis-
sion, a period of self-isolation of at least 10 days may be
wiser, particularly when an infected child may come into
contact with vulnerable subjects such as pregnant
women, newborns or immunocompromised people.
However, in order to validate our observation on viral
shedding further studies carried out in a bigger cohort of
children have to be performed.
In our study we evaluated viral shedding by identifying
viral RNA in nasopharyngeal secretions on the basis of
real-time PCR and because this method may amplify viral
RNA from non-viable virus particles [9] the true infection
period could have been not precisely evaluated. Only
classical virological methods (cell cultures and the deter-
mination of the 50% tissue culture infectious dose) can
give exact information concerning the amount replicating
viruses really shed by the patient.
Unlike what was expected on the basis of data collected
in subjects with seasonal influenza, the duration of pan-
demic A/H1N1/2009 influenz av i r u ss h e d d i n gw a sn o t
related to age because there was no difference between the
children in the different age groups. Children with seaso-
nal influenza shed viruses for longer than adults because
their lower pre-existing immunity fails to limit viral repli-
cation [1]. However, epidemiological data show that no
pediatric patient should have any pre-existing immunity
against a new virus such as the pandemic A/H1N1/2009
influenza virus [11]. This supports our finding of no age-
related difference in the shedding period.
In conclusion, our study confirms that, when a com-
pletely new influenza virus such as that present in a
pandemic begins to circulate, every precaution to limit
the spread of the infection should be taken regardless of
patient age and isolation period of infected children has
to be longer than the 7 days recommended for the
infections due to seasonal influenza viruses.
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